Fierce Pharma

A year after revealing his “Liberation Day” trade policy initiatives, [...]

As the battle for the weight-loss market expands to oral [...]

The company is looking to work out an arrangement with [...]

With a second phase 3 win for Tyvaso in idiopathic [...]

There’s no need to dive fast and furious into every [...]

Rocket has announced that the FDA signed off on an [...]

Takeda is launching a restructuring, targeting nearly $1.3 billion in [...]

CVC Capital Partners has offered to buy out the remaining [...]

Addressing pressing questions about the upcoming ATTR-CM competition and market [...]

After becoming a prominent public face of the CDC’s revamped [...]